SEROTONIN-2/1C RECEPTOR ACTIVATION CAUSES A LOCALIZED EXPRESSION OF THE IMMEDIATE-EARLY GENE C-FOS IN RAT-BRAIN - EVIDENCE FOR INVOLVEMENT OF DORSAL RAPHE NUCLEUS PROJECTION FIBERS

被引:83
作者
LESLIE, RA
MOORMAN, JM
COULSON, A
GRAHAMESMITH, DG
机构
[1] Oxford University-SmithKline Beecham Centre for Applied Neuropsychobiology, University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, OX2 6HE, Woodstock Road
关键词
D O I
10.1016/0306-4522(93)90209-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Immunocytochemistry has been used to monitor the expression of the immediate-early gene c-fos in rat brain following administration of the serotonin2/1C receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. At parenteral doses of 2 or 8mg/kg the drug caused a highly localized expression of the Fos protein in frontal, parietal, cingulate and piriform cortex as well as in claustrum, mamillary bodies, globus pallidus, amygdala, nucleus accumbens and dorsomedial striatum. In particular, the location of heavy Fos immunoreactivity in the primary somatosensory cortex corresponds precisely to that region (layer Va) shown in other reports to receive a dense input of fine, non-varicose fibres which may arise from the dorsal raphe nucleus. All of the Fos-positive brain regions in the present study have been previously demonstrated to contain serotonin, receptor ligand binding sites. Interestingly, no Fos-positive cells were found in the hippocampus, another brain region known to contain serotonin2 receptors. Pretreatment of animals with the serotonin2/1C receptor antagonist ritanserin (0.4mg/kg) markedly attenuated Fos expression in all reactive areas of the brain. Counts of reactive cells indicated that this antagonism of the Fos response was statistically significant in these brain regions. Spiperone (1 mg/kg), a mixed serotonin2 and dopamine D2 antagonist, also attenuated the Fos response in the same regions, but had the effect of inducing Fos expression on its own in other extrapyramidal brain regions. Double labelling of reactive cells with different antisera recognizing Fos and neuron-specific enolase, and lack of double labelling with a glial fibrillary acidic protein antiserum, indicated that the Fos expression was in neurons within the brain nuclei examined. The results indicate that the c-fos immunocytochemical technique is a valuable tool for studying the anatomy and pharmacology of serotonin receptors in experimental animal brain.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 19 条
[1]  
AGHAJANIAN GK, 1990, ANN NY ACAD SCI, V600, P93
[2]   CORRESPONDENCE BETWEEN 5-HT2 RECEPTORS AND SEROTONERGIC AXONS IN RAT NEOCORTEX [J].
BLUE, ME ;
YAGALOFF, KA ;
MAMOUNAS, LA ;
HARTIG, PR ;
MOLLIVER, ME .
BRAIN RESEARCH, 1988, 453 (1-2) :315-328
[3]   THE USE OF C-FOS AS A METABOLIC MARKER IN NEURONAL PATHWAY TRACING [J].
DRAGUNOW, M ;
FAULL, R .
JOURNAL OF NEUROSCIENCE METHODS, 1989, 29 (03) :261-265
[4]   D2 DOPAMINE RECEPTOR ANTAGONISTS INDUCE FOS AND RELATED PROTEINS IN RAT STRIATAL NEURONS [J].
DRAGUNOW, M ;
ROBERTSON, GS ;
FAULL, RLM ;
ROBERTSON, HA ;
JANSEN, K .
NEUROSCIENCE, 1990, 37 (02) :287-294
[5]   DOSE-DEPENDENT AND TIME-DEPENDENT EFFECTS OF 1-(2,5-DIMETHOXY-4-IODOPHENYL)-2-AMINOPROPANE (DOI), A SEROTONERGIC 5-HT2 RECEPTOR AGONIST, ON LOCAL CEREBRAL GLUCOSE-METABOLISM IN AWAKE RATS [J].
FREO, U ;
SONCRANT, TT ;
HOLLOWAY, HW ;
RAPOPORT, SI .
BRAIN RESEARCH, 1991, 541 (01) :63-69
[6]   EVIDENCE FOR 5-HT2 INVOLVEMENT IN THE MECHANISM OF ACTION OF HALLUCINOGENIC AGENTS [J].
GLENNON, RA ;
TITELER, M ;
MCKENNEY, JD .
LIFE SCIENCES, 1984, 35 (25) :2505-2511
[7]   5-HT1 AND 5-HT2 BINDING CHARACTERISTICS OF 1-(2,5-DIMETHOXY-4-BROMOPHENYL)-2-AMINOPROPANE ANALOGS [J].
GLENNON, RA ;
MCKENNEY, JD ;
LYON, RA ;
TITELER, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (02) :194-199
[8]   A BEHAVIORAL AND BIOCHEMICAL-STUDY IN MICE AND RATS OF PUTATIVE SELECTIVE AGONISTS AND ANTAGONISTS FOR 5-HT1-RECEPTOR AND 5-HT2-RECEPTOR [J].
GOODWIN, GM ;
GREEN, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 84 (03) :743-753
[9]   5-HT RECEPTORS - SUBTYPES AND 2ND MESSENGERS [J].
HOYER, D ;
SCHOEFFTER, P .
JOURNAL OF RECEPTOR RESEARCH, 1991, 11 (1-4) :197-214
[10]   POTENCIES OF ANTAGONISTS INDICATE THAT 5-HT1C RECEPTORS MEDIATE 1-3(CHLOROPHENYL)PIPERAZINE-INDUCED HYPOPHAGIA [J].
KENNETT, GA ;
CURZON, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (04) :2016-2020